"10.1371_journal.pone.0023946","plos one","2011-09-09T00:00:00Z","Matthias Stoll; Christian Kollan; Frank Bergmann; Johannes Bogner; Gerd Faetkenheuer; Carlos Fritzsche; Kirsten Hoeper; Heinz-August Horst; Jan van Lunzen; Andreas Plettenberg; Stefan Reuter; Jürgen Rockstroh; Hans-Jürgen Stellbrink; Osamah Hamouda; Barbara Bartmeyer; and the ClinSurv Study Group","Infectious Diseases Unit, Medical University, Hanover, Germany; Robert Koch Institute, Berlin, Germany; Charité University Medicine, Berlin, Germany; University Hospital, Ludwig-Maximilian University, Munich/München, Germany; University Hospital Cologne, Köln (Cologne), Germany; University Hospital, Rostock, Germany; University Schleswig Holstein, Kiel, Germany; University Hospital Eppendorf, Hamburg, Germany; Ifi-Institute for Interdisciplinary Medicine, Hamburg, Germany; University Hospital, Düsseldorf, Germany; University Hospital, Bonn, Germany; ICH Studycenter, Hamburg, Germany","Conceived and designed the experiments: MS CK KH OH. Performed the experiments: MS CK. Analyzed the data: MS BB CK KH. Contributed reagents/materials/analysis tools: MS FB JB GF CF H-AH JvL AP SR JR H-JS. Wrote the paper: MS BB CK.","The first author Matthias Stoll received honoraria as a lecturer by Abbott, Bristol-Myers-Squibb, Boehringer, Ingelheim, Glaxo-Smith-Kline, Roche, Gilead, Tibotec, Pfizer, Merck, Sharp & Dohme, and ViiV. He had served as a scientific advisor for Glaxo-Smith-Kline, Gilead, DuPont, Merck, Sharp & Dohme, Abbott, Roche, Solvay, Tibotec and ViiV. He received funding for scientific projects by Boehringer-Ingelheim, Glaxo-Smith-Kline, Roche, and Tibotec This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials.","2011","09","Matthias Stoll","MS",16,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
